# Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor System

> clinical trial · VERIFIED · 2026-07-10

Status: NOT_YET_RECRUITING · Sponsor: University Hospital, Basel, Switzerland · Condition: Atrial Fibrillation (Paroxysmal)

- Company: University Hospital, Basel, Switzerland
- Sector: Atrial Fibrillation (Paroxysmal)
- Primary source: https://clinicaltrials.gov/study/NCT07694570

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.